We only have this paper's title and publication details.
Read it at the sourceThese data suggest promise for the use of CSF TDP-43 as a biomarker for ALS.
No takes yet. Share an insight, caveat, or question.
Majumder et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: